Jing Tu

发表

Molecular inhibitory mechanism study on the potent inhibitor brigatinib against four crizotinib‐resistant ALK mutations

H. Zhai, X. Y. Zhang, Jing Tu, 2018, Journal of cellular biochemistry.

Insights into DFG-in and DFG-out JAK2 binding modes for a rational strategy of type II inhibitors combined computational study

H. Zhai, J. Li, Xiaoyun Zhang, 2016 .

Enhancing specificity in the Janus kinases: a study on the thienopyridine JAK2 selective mechanism combined molecular dynamics simulation.

H. Zhai, J. Li, X. Y. Zhang, 2016, Molecular bioSystems.

Molecular modeling study on resistance of WT/D473H SMO to antagonists LDE‐225 and LEQ‐506

H. Zhai, J. Li, X. Y. Zhang, 2017, Pharmacological research.

Design of novel quinoline-aminopiperidine derivatives as Mycobacterium tuberculosis (MTB) GyrB inhibitors: an in silico study

H. Zhai, Xiaoyun Zhang, Wenjuan Lv, 2018, Journal of biomolecular structure & dynamics.

Molecular mechanism study of several inhibitors binding to BRD9 bromodomain based on molecular simulations

H. Zhai, Jing Tu, L. Song, 2018, Journal of biomolecular structure & dynamics.

Synthesis and evaluation of Piperine analogs as thioredoxin reductase inhibitors to cause oxidative stress-induced cancer cell apoptosis.

Baoxin Zhang, Jing Tu, Jintao Zhao, 2023, Bioorganic chemistry.

Exploring the binding mechanism of Heteroaryldihydropyrimidines and Hepatitis B Virus capsid combined 3D‐QSAR and molecular dynamics

H. Zhai, J. Li, Jing Tu, 2017, Antiviral research.

Selective mechanisms and molecular design of 2,4 Diarylaminopyrimidines as ALK inhibitors.

H. Zhai, X. Y. Zhang, Jing Tu, 2018, International journal of biological macromolecules.